Home » Topics » Regulatory

Regulatory
RSS

Novartis seeks European marketing authorization for Myfortic

Nov. 7, 2001

New tablet formulations of linezolid claimed by Pharmacia

Nov. 6, 2001

Celebrex indications expanded with recent FDA approval

Nov. 6, 2001

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Shire's once-daily Adderall XR launched in U.S. for treatment of ADHD

Oct. 30, 2001

First regulatory approval obtained for Viread

Oct. 30, 2001

Successful completion of oxymorphone pain management clinical trial

Oct. 30, 2001

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...